Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bone Density | 65 | 2022 | 3471 | 3.990 |
Why?
|
Osteoporosis, Postmenopausal | 19 | 2022 | 386 | 2.540 |
Why?
|
Osteoporosis | 27 | 2023 | 1576 | 2.520 |
Why?
|
Fractures, Bone | 23 | 2023 | 1939 | 2.510 |
Why?
|
Vitamin D | 36 | 2023 | 3197 | 2.280 |
Why?
|
Cholecalciferol | 9 | 2023 | 534 | 2.210 |
Why?
|
Fatty Acids, Omega-3 | 9 | 2023 | 1338 | 2.200 |
Why?
|
Osteoporotic Fractures | 12 | 2022 | 400 | 1.970 |
Why?
|
Bone Density Conservation Agents | 10 | 2022 | 771 | 1.720 |
Why?
|
Body Composition | 17 | 2021 | 2397 | 1.630 |
Why?
|
Vitamin D Deficiency | 11 | 2023 | 1327 | 1.590 |
Why?
|
Hip Fractures | 18 | 2022 | 953 | 1.560 |
Why?
|
Absorptiometry, Photon | 32 | 2021 | 1726 | 1.470 |
Why?
|
Dietary Supplements | 22 | 2023 | 3279 | 1.450 |
Why?
|
Women's Health | 21 | 2023 | 2029 | 1.350 |
Why?
|
Postmenopause | 29 | 2021 | 2456 | 1.250 |
Why?
|
Accidental Falls | 6 | 2023 | 1055 | 1.230 |
Why?
|
Femur Neck | 11 | 2020 | 309 | 1.110 |
Why?
|
Cacao | 2 | 2023 | 98 | 1.020 |
Why?
|
Diet, Reducing | 6 | 2019 | 460 | 0.900 |
Why?
|
Dehydroepiandrosterone | 7 | 2016 | 252 | 0.900 |
Why?
|
Alendronate | 2 | 2020 | 172 | 0.780 |
Why?
|
Vitamins | 13 | 2023 | 1602 | 0.770 |
Why?
|
Parathyroid Hormone | 23 | 2023 | 1799 | 0.640 |
Why?
|
Calcium | 27 | 2023 | 5742 | 0.630 |
Why?
|
Overweight | 7 | 2023 | 2355 | 0.630 |
Why?
|
Bone and Bones | 8 | 2021 | 2575 | 0.600 |
Why?
|
Osteoarthritis, Hip | 4 | 2011 | 410 | 0.560 |
Why?
|
Double-Blind Method | 18 | 2023 | 11985 | 0.530 |
Why?
|
Weight Loss | 7 | 2023 | 2589 | 0.520 |
Why?
|
Mesenchymal Stem Cells | 6 | 2020 | 1618 | 0.520 |
Why?
|
Aged | 86 | 2023 | 162698 | 0.510 |
Why?
|
Spine | 6 | 2017 | 1144 | 0.500 |
Why?
|
Femur | 12 | 2018 | 1297 | 0.490 |
Why?
|
Ulna Fractures | 1 | 2015 | 125 | 0.480 |
Why?
|
Anorexia Nervosa | 6 | 2014 | 1284 | 0.470 |
Why?
|
Minerals | 4 | 2011 | 275 | 0.470 |
Why?
|
Women | 1 | 2015 | 230 | 0.460 |
Why?
|
Dehydroepiandrosterone Sulfate | 4 | 2006 | 238 | 0.450 |
Why?
|
Bone Remodeling | 4 | 2018 | 575 | 0.450 |
Why?
|
Primary Ovarian Insufficiency | 2 | 2011 | 114 | 0.450 |
Why?
|
Middle Aged | 93 | 2023 | 212863 | 0.440 |
Why?
|
Wrist Injuries | 1 | 2015 | 208 | 0.440 |
Why?
|
Female | 125 | 2023 | 378853 | 0.440 |
Why?
|
Bone Resorption | 6 | 2014 | 726 | 0.390 |
Why?
|
Femoral Neck Fractures | 1 | 2012 | 138 | 0.380 |
Why?
|
Bone Diseases, Metabolic | 2 | 2017 | 417 | 0.370 |
Why?
|
Obesity | 12 | 2023 | 12643 | 0.370 |
Why?
|
Calcium, Dietary | 6 | 2017 | 526 | 0.370 |
Why?
|
Osteoblasts | 6 | 2020 | 1163 | 0.360 |
Why?
|
Humans | 157 | 2023 | 739398 | 0.360 |
Why?
|
Weight Gain | 3 | 2023 | 2278 | 0.350 |
Why?
|
Radius Fractures | 1 | 2015 | 497 | 0.350 |
Why?
|
Estrogens, Conjugated (USP) | 4 | 2023 | 275 | 0.340 |
Why?
|
Parathyroid Glands | 12 | 1990 | 509 | 0.340 |
Why?
|
Osteogenesis | 5 | 2020 | 1292 | 0.330 |
Why?
|
Hyperhomocysteinemia | 1 | 2009 | 124 | 0.320 |
Why?
|
Radius | 1 | 2011 | 422 | 0.320 |
Why?
|
Estrogen Replacement Therapy | 8 | 2023 | 1203 | 0.310 |
Why?
|
Aging | 10 | 2018 | 8613 | 0.300 |
Why?
|
Estrogens | 4 | 2023 | 1561 | 0.300 |
Why?
|
Insulin-Like Growth Factor I | 6 | 2016 | 2015 | 0.290 |
Why?
|
Celiac Disease | 2 | 2013 | 783 | 0.280 |
Why?
|
Diphosphonates | 5 | 2022 | 624 | 0.270 |
Why?
|
Homocysteine | 1 | 2009 | 647 | 0.260 |
Why?
|
Tibia | 1 | 2011 | 1072 | 0.260 |
Why?
|
Bone Marrow Cells | 7 | 2019 | 2515 | 0.260 |
Why?
|
Osteocalcin | 5 | 2002 | 273 | 0.250 |
Why?
|
Dietary Fats | 5 | 2019 | 2013 | 0.250 |
Why?
|
Dietary Proteins | 3 | 2017 | 959 | 0.250 |
Why?
|
Risk Factors | 31 | 2023 | 71974 | 0.240 |
Why?
|
Adiposity | 4 | 2021 | 1801 | 0.240 |
Why?
|
Prednisone | 3 | 1995 | 1560 | 0.240 |
Why?
|
Male | 55 | 2023 | 349022 | 0.240 |
Why?
|
Drug Therapy | 1 | 2006 | 497 | 0.230 |
Why?
|
Alkaline Phosphatase | 5 | 2012 | 864 | 0.230 |
Why?
|
Etidronic Acid | 1 | 2003 | 64 | 0.220 |
Why?
|
Premenopause | 5 | 2011 | 1028 | 0.210 |
Why?
|
Survivors | 4 | 2016 | 2280 | 0.210 |
Why?
|
RANK Ligand | 3 | 2014 | 325 | 0.210 |
Why?
|
Plant Extracts | 2 | 2023 | 464 | 0.210 |
Why?
|
Exercise | 6 | 2023 | 5591 | 0.210 |
Why?
|
Breast Neoplasms | 8 | 2016 | 20676 | 0.210 |
Why?
|
Stromal Cells | 4 | 2019 | 1350 | 0.210 |
Why?
|
Calcifediol | 3 | 2012 | 166 | 0.210 |
Why?
|
Lower Extremity | 2 | 2017 | 1145 | 0.200 |
Why?
|
Adult | 51 | 2023 | 213394 | 0.200 |
Why?
|
Medroxyprogesterone Acetate | 4 | 2023 | 162 | 0.200 |
Why?
|
Triamcinolone Acetonide | 1 | 2001 | 101 | 0.190 |
Why?
|
Fatty Acids, Volatile | 1 | 2021 | 101 | 0.190 |
Why?
|
Progestins | 2 | 2012 | 303 | 0.190 |
Why?
|
Incidence | 8 | 2020 | 20913 | 0.190 |
Why?
|
Forearm | 3 | 2020 | 407 | 0.180 |
Why?
|
Arthroplasty, Replacement, Hip | 3 | 2013 | 1457 | 0.180 |
Why?
|
Aged, 80 and over | 20 | 2023 | 57650 | 0.180 |
Why?
|
Men's Health | 1 | 2020 | 72 | 0.180 |
Why?
|
Survival | 1 | 2020 | 162 | 0.180 |
Why?
|
Body Mass Index | 11 | 2023 | 12655 | 0.180 |
Why?
|
Lumbar Vertebrae | 6 | 2017 | 1843 | 0.180 |
Why?
|
Estradiol | 4 | 2017 | 2021 | 0.180 |
Why?
|
Kidney Failure, Chronic | 3 | 2009 | 2546 | 0.170 |
Why?
|
Glucocorticoids | 2 | 2001 | 2100 | 0.170 |
Why?
|
Menstrual Cycle | 2 | 2002 | 550 | 0.170 |
Why?
|
Tamoxifen | 2 | 2016 | 978 | 0.170 |
Why?
|
Follow-Up Studies | 10 | 2021 | 38942 | 0.170 |
Why?
|
Monitoring, Physiologic | 1 | 2007 | 1735 | 0.170 |
Why?
|
Whole Body Imaging | 1 | 2021 | 285 | 0.170 |
Why?
|
Methylamines | 1 | 2019 | 117 | 0.160 |
Why?
|
Tea | 1 | 2020 | 274 | 0.160 |
Why?
|
Osteoprotegerin | 3 | 2014 | 174 | 0.160 |
Why?
|
Leiomyoma | 2 | 1994 | 727 | 0.160 |
Why?
|
Cohort Studies | 11 | 2023 | 40389 | 0.160 |
Why?
|
Intra-Abdominal Fat | 2 | 2021 | 590 | 0.160 |
Why?
|
Osteomalacia | 2 | 2002 | 53 | 0.150 |
Why?
|
Amenorrhea | 1 | 2001 | 485 | 0.150 |
Why?
|
Dietary Carbohydrates | 2 | 2013 | 904 | 0.150 |
Why?
|
Dietary Fiber | 1 | 2021 | 759 | 0.150 |
Why?
|
Spinal Fractures | 3 | 2017 | 697 | 0.140 |
Why?
|
Case-Control Studies | 11 | 2018 | 21694 | 0.140 |
Why?
|
Calcium Carbonate | 1 | 2016 | 67 | 0.140 |
Why?
|
Foundations | 1 | 2016 | 94 | 0.140 |
Why?
|
Hip Joint | 3 | 2015 | 1000 | 0.140 |
Why?
|
Contraceptives, Oral, Combined | 2 | 2014 | 113 | 0.140 |
Why?
|
Waist Circumference | 3 | 2015 | 912 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 3 | 2017 | 20055 | 0.130 |
Why?
|
Hostility | 1 | 2016 | 189 | 0.130 |
Why?
|
Cardiovascular Diseases | 5 | 2023 | 15070 | 0.130 |
Why?
|
Menopause | 4 | 2023 | 1613 | 0.130 |
Why?
|
Plant Proteins | 1 | 2018 | 361 | 0.130 |
Why?
|
Leuprolide | 2 | 1994 | 303 | 0.130 |
Why?
|
Primary Prevention | 2 | 2020 | 1165 | 0.130 |
Why?
|
gamma-Tocopherol | 1 | 2015 | 31 | 0.130 |
Why?
|
Antineoplastic Agents | 3 | 2011 | 13635 | 0.130 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2016 | 170 | 0.130 |
Why?
|
Coffee | 1 | 2020 | 577 | 0.130 |
Why?
|
Prospective Studies | 17 | 2020 | 53037 | 0.130 |
Why?
|
Netherlands | 1 | 2020 | 2169 | 0.130 |
Why?
|
Group Processes | 1 | 2016 | 225 | 0.130 |
Why?
|
Spondylitis, Ankylosing | 1 | 1996 | 152 | 0.130 |
Why?
|
Gastrointestinal Diseases | 1 | 2003 | 1162 | 0.120 |
Why?
|
Confidence Intervals | 3 | 2016 | 2974 | 0.120 |
Why?
|
Cell Differentiation | 7 | 2020 | 11460 | 0.120 |
Why?
|
Uterine Neoplasms | 2 | 1994 | 1511 | 0.120 |
Why?
|
Radioimmunoassay | 3 | 2007 | 918 | 0.120 |
Why?
|
Fibroblast Growth Factors | 1 | 2020 | 879 | 0.120 |
Why?
|
Interleukin-6 | 2 | 2001 | 3194 | 0.120 |
Why?
|
beta Carotene | 1 | 2015 | 526 | 0.120 |
Why?
|
Receptor, IGF Type 1 | 1 | 2016 | 390 | 0.110 |
Why?
|
Food Preferences | 1 | 2017 | 398 | 0.110 |
Why?
|
Hormone Replacement Therapy | 3 | 2014 | 740 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2023 | 9812 | 0.110 |
Why?
|
Antioxidants | 2 | 2015 | 1659 | 0.110 |
Why?
|
Fractures, Spontaneous | 2 | 2008 | 230 | 0.110 |
Why?
|
Collagen Type I | 3 | 2018 | 577 | 0.110 |
Why?
|
Osteoclasts | 2 | 2014 | 731 | 0.110 |
Why?
|
Calcitonin | 2 | 2006 | 336 | 0.110 |
Why?
|
Hypocalcemia | 2 | 1991 | 191 | 0.110 |
Why?
|
Baltimore | 1 | 2013 | 230 | 0.110 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2011 | 11410 | 0.110 |
Why?
|
Sarcopenia | 1 | 2017 | 364 | 0.110 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2020 | 2216 | 0.110 |
Why?
|
Sodium, Dietary | 1 | 2016 | 416 | 0.110 |
Why?
|
Neoplasms | 4 | 2023 | 21507 | 0.100 |
Why?
|
Aromatase Inhibitors | 1 | 2016 | 490 | 0.100 |
Why?
|
Obesity, Abdominal | 1 | 2015 | 360 | 0.100 |
Why?
|
Calcification, Physiologic | 1 | 2012 | 169 | 0.100 |
Why?
|
United States | 12 | 2021 | 69573 | 0.100 |
Why?
|
Smoking | 5 | 2023 | 8960 | 0.100 |
Why?
|
Leptin | 1 | 2019 | 1589 | 0.100 |
Why?
|
Transglutaminases | 1 | 2013 | 193 | 0.100 |
Why?
|
Activities of Daily Living | 2 | 2023 | 2410 | 0.100 |
Why?
|
Sex Factors | 4 | 2020 | 10398 | 0.100 |
Why?
|
Tensile Strength | 1 | 2012 | 332 | 0.100 |
Why?
|
Adipose Tissue | 5 | 2021 | 3280 | 0.100 |
Why?
|
Self Report | 3 | 2017 | 3524 | 0.100 |
Why?
|
Guanylyl Imidodiphosphate | 1 | 1990 | 36 | 0.100 |
Why?
|
Radiography | 4 | 2017 | 6998 | 0.100 |
Why?
|
Biomedical Research | 2 | 2020 | 3301 | 0.090 |
Why?
|
Hand Strength | 2 | 2017 | 441 | 0.090 |
Why?
|
Societies, Scientific | 1 | 2011 | 220 | 0.090 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2011 | 3453 | 0.090 |
Why?
|
Body Height | 1 | 2016 | 1577 | 0.090 |
Why?
|
GTP-Binding Proteins | 4 | 2013 | 972 | 0.090 |
Why?
|
Biological Availability | 2 | 2018 | 390 | 0.090 |
Why?
|
Cyclosporine | 1 | 1992 | 781 | 0.090 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2019 | 11699 | 0.090 |
Why?
|
Guanosine Triphosphate | 1 | 1990 | 320 | 0.090 |
Why?
|
Renal Insufficiency | 1 | 1995 | 803 | 0.090 |
Why?
|
Hyperparathyroidism | 4 | 1999 | 339 | 0.090 |
Why?
|
Risk Assessment | 10 | 2022 | 23294 | 0.090 |
Why?
|
Practice Guidelines as Topic | 3 | 2016 | 7274 | 0.090 |
Why?
|
Drug Therapy, Combination | 5 | 2015 | 6478 | 0.090 |
Why?
|
Immunoglobulin A | 1 | 2013 | 989 | 0.080 |
Why?
|
Cystatins | 1 | 2008 | 55 | 0.080 |
Why?
|
Multiple Sclerosis | 1 | 2023 | 3065 | 0.080 |
Why?
|
Orthopedics | 2 | 2015 | 900 | 0.080 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1522 | 0.080 |
Why?
|
Disability Evaluation | 1 | 2016 | 1824 | 0.080 |
Why?
|
Life Style | 1 | 2020 | 3817 | 0.080 |
Why?
|
Health | 1 | 2011 | 390 | 0.080 |
Why?
|
Probability | 4 | 2011 | 2500 | 0.080 |
Why?
|
Geriatric Assessment | 1 | 2016 | 1366 | 0.080 |
Why?
|
Levonorgestrel | 2 | 2012 | 77 | 0.080 |
Why?
|
Body Size | 1 | 2011 | 458 | 0.080 |
Why?
|
Ethinyl Estradiol | 2 | 2012 | 116 | 0.080 |
Why?
|
Cyclic AMP | 4 | 1990 | 1470 | 0.080 |
Why?
|
Nutritional Status | 4 | 2019 | 1587 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2021 | 7897 | 0.080 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2020 | 3615 | 0.080 |
Why?
|
Health Status | 3 | 2016 | 4013 | 0.080 |
Why?
|
Diet | 4 | 2020 | 7876 | 0.070 |
Why?
|
Calcitriol | 3 | 2012 | 298 | 0.070 |
Why?
|
Gonadal Steroid Hormones | 2 | 2008 | 711 | 0.070 |
Why?
|
Hypertension | 5 | 2021 | 8431 | 0.070 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 1993 | 1187 | 0.070 |
Why?
|
Cattle | 10 | 2004 | 3913 | 0.070 |
Why?
|
Fluorouracil | 1 | 2011 | 1609 | 0.070 |
Why?
|
Reference Values | 5 | 2003 | 4983 | 0.070 |
Why?
|
Bone Neoplasms | 1 | 1999 | 2521 | 0.070 |
Why?
|
Diet, Fat-Restricted | 1 | 2009 | 316 | 0.070 |
Why?
|
Mendelian Randomization Analysis | 2 | 2023 | 950 | 0.070 |
Why?
|
Reproducibility of Results | 5 | 2011 | 19811 | 0.070 |
Why?
|
Receptors, Calcitriol | 2 | 2020 | 350 | 0.070 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2009 | 256 | 0.070 |
Why?
|
Kidney Function Tests | 1 | 2008 | 681 | 0.070 |
Why?
|
25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 2 | 2020 | 61 | 0.070 |
Why?
|
Longitudinal Studies | 8 | 2018 | 13880 | 0.070 |
Why?
|
Cyclophosphamide | 1 | 2011 | 2238 | 0.070 |
Why?
|
Recovery of Function | 2 | 2008 | 2924 | 0.070 |
Why?
|
Depressive Disorder, Major | 1 | 2023 | 4606 | 0.070 |
Why?
|
Binding, Competitive | 1 | 2007 | 1158 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2018 | 10945 | 0.070 |
Why?
|
Bone Diseases | 1 | 2009 | 417 | 0.070 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2008 | 548 | 0.070 |
Why?
|
Doxorubicin | 1 | 2011 | 2218 | 0.060 |
Why?
|
Methotrexate | 1 | 2011 | 1711 | 0.060 |
Why?
|
Body Weight | 4 | 2015 | 4660 | 0.060 |
Why?
|
Predictive Value of Tests | 3 | 2018 | 15036 | 0.060 |
Why?
|
Regression Analysis | 4 | 2002 | 6452 | 0.060 |
Why?
|
Arthritis, Rheumatoid | 2 | 2009 | 3689 | 0.060 |
Why?
|
Sex Characteristics | 1 | 2015 | 2583 | 0.060 |
Why?
|
Progesterone Congeners | 1 | 2003 | 42 | 0.060 |
Why?
|
Subcutaneous Fat | 2 | 2021 | 392 | 0.060 |
Why?
|
Peptides | 3 | 2018 | 4395 | 0.060 |
Why?
|
Energy Intake | 3 | 2012 | 2135 | 0.060 |
Why?
|
Cross-Sectional Studies | 8 | 2012 | 24714 | 0.060 |
Why?
|
Hip | 3 | 2014 | 257 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3606 | 0.060 |
Why?
|
Societies, Medical | 1 | 2015 | 3739 | 0.060 |
Why?
|
Inositol Phosphates | 3 | 2004 | 180 | 0.060 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2011 | 941 | 0.060 |
Why?
|
Chromatography, Liquid | 1 | 2007 | 977 | 0.060 |
Why?
|
Hypoparathyroidism | 1 | 2004 | 120 | 0.060 |
Why?
|
Drug Administration Schedule | 3 | 1999 | 4935 | 0.050 |
Why?
|
Receptors, Calcium-Sensing | 1 | 2004 | 315 | 0.050 |
Why?
|
Prevalence | 5 | 2013 | 15153 | 0.050 |
Why?
|
Collagen | 2 | 2002 | 2671 | 0.050 |
Why?
|
Thyroglobulin | 1 | 1982 | 114 | 0.050 |
Why?
|
Age Factors | 2 | 2018 | 18349 | 0.050 |
Why?
|
Veterans | 1 | 2016 | 2505 | 0.050 |
Why?
|
Digestive System | 1 | 2003 | 251 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5272 | 0.050 |
Why?
|
Boston | 2 | 2013 | 9314 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2020 | 62693 | 0.050 |
Why?
|
Dihydrotestosterone | 1 | 2001 | 188 | 0.050 |
Why?
|
Depression | 2 | 2023 | 7689 | 0.050 |
Why?
|
C-Reactive Protein | 1 | 2013 | 3752 | 0.050 |
Why?
|
Intestinal Absorption | 1 | 1982 | 420 | 0.050 |
Why?
|
Cells, Cultured | 6 | 2019 | 19220 | 0.050 |
Why?
|
Severity of Illness Index | 3 | 2010 | 15511 | 0.050 |
Why?
|
Drug Tolerance | 1 | 2003 | 376 | 0.050 |
Why?
|
Renin | 2 | 1982 | 637 | 0.050 |
Why?
|
Triiodothyronine | 1 | 1982 | 491 | 0.050 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2002 | 370 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2022 | 11668 | 0.050 |
Why?
|
Cytosol | 4 | 1989 | 902 | 0.050 |
Why?
|
Administration, Oral | 3 | 1999 | 3909 | 0.050 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3233 | 0.040 |
Why?
|
Delayed-Action Preparations | 2 | 1994 | 962 | 0.040 |
Why?
|
Hypoglycemic Agents | 1 | 2012 | 2861 | 0.040 |
Why?
|
Bone Morphogenetic Protein 7 | 1 | 2020 | 112 | 0.040 |
Why?
|
Homeostasis | 1 | 1991 | 3348 | 0.040 |
Why?
|
Adolescent | 9 | 2014 | 85405 | 0.040 |
Why?
|
Mass Spectrometry | 1 | 2007 | 2200 | 0.040 |
Why?
|
Calcium Channel Blockers | 2 | 1995 | 686 | 0.040 |
Why?
|
Pelvic Bones | 1 | 2001 | 264 | 0.040 |
Why?
|
Stroke | 1 | 2022 | 9898 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 15500 | 0.040 |
Why?
|
Heart Transplantation | 1 | 1992 | 3109 | 0.040 |
Why?
|
Follicle Stimulating Hormone | 1 | 2001 | 739 | 0.040 |
Why?
|
Multivariate Analysis | 4 | 2009 | 12237 | 0.040 |
Why?
|
Health Policy | 1 | 2011 | 2655 | 0.040 |
Why?
|
Thyroxine | 1 | 1982 | 666 | 0.040 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2020 | 250 | 0.040 |
Why?
|
Administration, Inhalation | 1 | 2001 | 1099 | 0.040 |
Why?
|
Receptors, Estrogen | 1 | 2006 | 2183 | 0.040 |
Why?
|
Gastrectomy | 1 | 2003 | 642 | 0.040 |
Why?
|
Hormones | 1 | 2022 | 880 | 0.040 |
Why?
|
Carnitine | 1 | 2019 | 239 | 0.040 |
Why?
|
Metabolic Equivalent | 1 | 2017 | 14 | 0.040 |
Why?
|
Procollagen | 1 | 2018 | 185 | 0.040 |
Why?
|
Quality of Life | 2 | 2016 | 12640 | 0.040 |
Why?
|
Captopril | 3 | 1984 | 271 | 0.040 |
Why?
|
Vitamin D-Binding Protein | 1 | 2018 | 130 | 0.040 |
Why?
|
Frail Elderly | 2 | 2016 | 690 | 0.040 |
Why?
|
Body Image | 1 | 2002 | 608 | 0.040 |
Why?
|
Choline | 1 | 2019 | 488 | 0.040 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2018 | 167 | 0.040 |
Why?
|
Glomerular Filtration Rate | 2 | 2020 | 2184 | 0.040 |
Why?
|
Medication Adherence | 1 | 2009 | 2047 | 0.040 |
Why?
|
Cystic Fibrosis | 1 | 2006 | 1177 | 0.040 |
Why?
|
Peptide Fragments | 3 | 2018 | 5076 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2016 | 12049 | 0.040 |
Why?
|
Parathyroidectomy | 1 | 1999 | 234 | 0.040 |
Why?
|
Drug Combinations | 2 | 2011 | 1959 | 0.040 |
Why?
|
Weight-Bearing | 2 | 2011 | 515 | 0.040 |
Why?
|
Linear Models | 3 | 2009 | 5948 | 0.030 |
Why?
|
Protein-Energy Malnutrition | 2 | 1995 | 187 | 0.030 |
Why?
|
Hydroxycholecalciferols | 1 | 1995 | 44 | 0.030 |
Why?
|
Alcohol Drinking | 1 | 2009 | 3945 | 0.030 |
Why?
|
Comorbidity | 2 | 2016 | 10362 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 1982 | 1510 | 0.030 |
Why?
|
Autoantibodies | 1 | 2004 | 2020 | 0.030 |
Why?
|
Educational Status | 1 | 2023 | 2514 | 0.030 |
Why?
|
Time Factors | 7 | 2017 | 40050 | 0.030 |
Why?
|
Hypercalcemia | 2 | 1989 | 405 | 0.030 |
Why?
|
Thyrotropin | 1 | 1999 | 849 | 0.030 |
Why?
|
Estradiol Congeners | 1 | 1994 | 28 | 0.030 |
Why?
|
Liver Diseases | 1 | 2003 | 1244 | 0.030 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 1995 | 126 | 0.030 |
Why?
|
Logistic Models | 4 | 2016 | 13402 | 0.030 |
Why?
|
Norethindrone | 1 | 1994 | 59 | 0.030 |
Why?
|
Protein Binding | 1 | 2007 | 9375 | 0.030 |
Why?
|
Receptor Activator of Nuclear Factor-kappa B | 1 | 2014 | 79 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2021 | 35326 | 0.030 |
Why?
|
Receptor, Macrophage Colony-Stimulating Factor | 1 | 2014 | 87 | 0.030 |
Why?
|
Proportional Hazards Models | 3 | 2016 | 12328 | 0.030 |
Why?
|
Calcium-Binding Proteins | 2 | 1997 | 1078 | 0.030 |
Why?
|
Phosphates | 2 | 1995 | 785 | 0.030 |
Why?
|
Puberty | 1 | 2017 | 494 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2016 | 489 | 0.030 |
Why?
|
Sensitivity and Specificity | 4 | 2007 | 14740 | 0.030 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 2014 | 186 | 0.030 |
Why?
|
Waist-Hip Ratio | 1 | 2015 | 517 | 0.030 |
Why?
|
Citrates | 2 | 1991 | 132 | 0.030 |
Why?
|
ROC Curve | 2 | 2018 | 3526 | 0.030 |
Why?
|
Estrone | 1 | 1994 | 239 | 0.030 |
Why?
|
Estrogen Receptor alpha | 1 | 2017 | 575 | 0.030 |
Why?
|
Hematocrit | 1 | 1994 | 636 | 0.030 |
Why?
|
Medroxyprogesterone | 1 | 1992 | 37 | 0.030 |
Why?
|
Health Surveys | 2 | 2016 | 4022 | 0.030 |
Why?
|
Calibration | 1 | 1995 | 818 | 0.030 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 691 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2008 | 76631 | 0.030 |
Why?
|
Liver Transplantation | 1 | 2003 | 2110 | 0.030 |
Why?
|
Disease Progression | 1 | 2009 | 13237 | 0.030 |
Why?
|
Nutrition Assessment | 1 | 1995 | 717 | 0.030 |
Why?
|
Cholesterol | 2 | 2013 | 2900 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2021 | 2039 | 0.030 |
Why?
|
Vitamin A | 1 | 2015 | 613 | 0.030 |
Why?
|
Autoimmune Diseases | 1 | 2004 | 2116 | 0.030 |
Why?
|
Mobility Limitation | 1 | 2016 | 403 | 0.030 |
Why?
|
Blood Pressure | 3 | 2021 | 8554 | 0.030 |
Why?
|
Demography | 1 | 2016 | 1650 | 0.030 |
Why?
|
Angiotensin II | 3 | 1984 | 880 | 0.020 |
Why?
|
Systems Theory | 1 | 2011 | 59 | 0.020 |
Why?
|
Personal Satisfaction | 1 | 2016 | 629 | 0.020 |
Why?
|
Cytokines | 2 | 2006 | 7298 | 0.020 |
Why?
|
Kinetics | 3 | 1991 | 6475 | 0.020 |
Why?
|
Electric Impedance | 1 | 1995 | 720 | 0.020 |
Why?
|
Androgens | 1 | 1999 | 1270 | 0.020 |
Why?
|
Growth Hormone | 1 | 1993 | 703 | 0.020 |
Why?
|
Health Planning Guidelines | 1 | 2011 | 163 | 0.020 |
Why?
|
Proline | 2 | 1984 | 454 | 0.020 |
Why?
|
Citric Acid | 1 | 1991 | 126 | 0.020 |
Why?
|
Body Constitution | 1 | 2011 | 273 | 0.020 |
Why?
|
Guanine Nucleotides | 2 | 1987 | 68 | 0.020 |
Why?
|
Periosteum | 1 | 2011 | 138 | 0.020 |
Why?
|
Knee Prosthesis | 1 | 1994 | 425 | 0.020 |
Why?
|
Compressive Strength | 1 | 2011 | 168 | 0.020 |
Why?
|
Isoproterenol | 1 | 1990 | 399 | 0.020 |
Why?
|
Animals | 15 | 2018 | 168368 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2005 | 4920 | 0.020 |
Why?
|
Creatinine | 1 | 1995 | 1903 | 0.020 |
Why?
|
Abdominal Fat | 1 | 2012 | 223 | 0.020 |
Why?
|
Patient Compliance | 2 | 2012 | 2679 | 0.020 |
Why?
|
Steroid Hydroxylases | 1 | 2009 | 96 | 0.020 |
Why?
|
Postpartum Period | 1 | 1996 | 1070 | 0.020 |
Why?
|
Mexican Americans | 1 | 2010 | 165 | 0.020 |
Why?
|
Second Messenger Systems | 1 | 1990 | 206 | 0.020 |
Why?
|
Case Management | 1 | 2011 | 287 | 0.020 |
Why?
|
New Mexico | 1 | 2009 | 86 | 0.020 |
Why?
|
Observer Variation | 1 | 1995 | 2589 | 0.020 |
Why?
|
Rheumatic Diseases | 1 | 1995 | 590 | 0.020 |
Why?
|
Lithium | 2 | 1989 | 603 | 0.020 |
Why?
|
Diltiazem | 1 | 1989 | 133 | 0.020 |
Why?
|
Satiation | 1 | 2009 | 80 | 0.020 |
Why?
|
Parenteral Nutrition | 1 | 1993 | 649 | 0.020 |
Why?
|
Uterus | 1 | 1993 | 712 | 0.020 |
Why?
|
Feasibility Studies | 1 | 1999 | 5058 | 0.020 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2003 | 2397 | 0.020 |
Why?
|
Permeability | 1 | 1990 | 739 | 0.020 |
Why?
|
Young Adult | 2 | 2012 | 56255 | 0.020 |
Why?
|
Sunlight | 1 | 2010 | 324 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 1997 | 2864 | 0.020 |
Why?
|
Sugar Phosphates | 1 | 1987 | 41 | 0.020 |
Why?
|
Enteral Nutrition | 1 | 1993 | 758 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 1994 | 1807 | 0.020 |
Why?
|
Geography | 1 | 2010 | 672 | 0.020 |
Why?
|
Protein Kinase C | 3 | 1987 | 1223 | 0.020 |
Why?
|
Gene Expression | 2 | 2017 | 7788 | 0.020 |
Why?
|
Cystatin C | 1 | 2008 | 250 | 0.020 |
Why?
|
Algorithms | 1 | 2007 | 13872 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 1995 | 2504 | 0.020 |
Why?
|
Parathyroid Diseases | 1 | 1987 | 48 | 0.020 |
Why?
|
Postoperative Care | 1 | 1993 | 1477 | 0.020 |
Why?
|
Fasting | 1 | 2013 | 1587 | 0.020 |
Why?
|
Indians, North American | 1 | 2010 | 352 | 0.020 |
Why?
|
3',5'-Cyclic-AMP Phosphodiesterases | 1 | 1986 | 50 | 0.020 |
Why?
|
Egtazic Acid | 1 | 1986 | 173 | 0.020 |
Why?
|
Placebos | 1 | 2011 | 1678 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2018 | 3180 | 0.020 |
Why?
|
Aminoquinolines | 1 | 1986 | 108 | 0.020 |
Why?
|
Proteins | 2 | 1999 | 6082 | 0.020 |
Why?
|
Social Support | 1 | 2016 | 2112 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2016 | 2933 | 0.020 |
Why?
|
Renal Dialysis | 1 | 1995 | 1780 | 0.020 |
Why?
|
Odds Ratio | 2 | 2008 | 9846 | 0.020 |
Why?
|
Exocytosis | 1 | 1987 | 354 | 0.020 |
Why?
|
Lung Diseases | 1 | 1995 | 1879 | 0.020 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1986 | 821 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2012 | 2533 | 0.020 |
Why?
|
Femoral Fractures | 1 | 2008 | 376 | 0.020 |
Why?
|
Kidney | 1 | 2020 | 7144 | 0.020 |
Why?
|
Diabetes Mellitus | 2 | 2009 | 5702 | 0.010 |
Why?
|
Seasons | 1 | 2010 | 1486 | 0.010 |
Why?
|
Genotype | 1 | 2018 | 12951 | 0.010 |
Why?
|
Hand | 1 | 2009 | 875 | 0.010 |
Why?
|
Magnesium | 1 | 1987 | 812 | 0.010 |
Why?
|
Physical Fitness | 1 | 2008 | 733 | 0.010 |
Why?
|
Addison Disease | 1 | 2004 | 48 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 2 | 2018 | 17384 | 0.010 |
Why?
|
Calcimycin | 1 | 1983 | 222 | 0.010 |
Why?
|
Walking | 1 | 2011 | 1177 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2007 | 2345 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2004 | 829 | 0.010 |
Why?
|
Asthma | 1 | 2001 | 5950 | 0.010 |
Why?
|
Adrenal Glands | 2 | 2001 | 545 | 0.010 |
Why?
|
Tissue Extracts | 1 | 1982 | 135 | 0.010 |
Why?
|
Graves Disease | 1 | 2004 | 241 | 0.010 |
Why?
|
Ascorbic Acid | 1 | 2005 | 649 | 0.010 |
Why?
|
Anthropometry | 1 | 2007 | 1344 | 0.010 |
Why?
|
Imidazoles | 1 | 2007 | 1207 | 0.010 |
Why?
|
Prostaglandins E | 1 | 1981 | 180 | 0.010 |
Why?
|
Desoxycorticosterone | 1 | 1980 | 50 | 0.010 |
Why?
|
Motor Activity | 1 | 2011 | 2719 | 0.010 |
Why?
|
Counseling | 1 | 2009 | 1526 | 0.010 |
Why?
|
Models, Statistical | 1 | 1995 | 5113 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2015 | 10961 | 0.010 |
Why?
|
Metabolic Clearance Rate | 3 | 1988 | 380 | 0.010 |
Why?
|
Hospitalization | 2 | 2011 | 10208 | 0.010 |
Why?
|
Ultrasonography | 1 | 1993 | 5941 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1983 | 2665 | 0.010 |
Why?
|
Aldosterone | 2 | 1984 | 870 | 0.010 |
Why?
|
Attitude to Health | 1 | 2009 | 2047 | 0.010 |
Why?
|
Forecasting | 1 | 2009 | 2952 | 0.010 |
Why?
|
Age Distribution | 1 | 2005 | 2904 | 0.010 |
Why?
|
Antirheumatic Agents | 1 | 2009 | 1329 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 2008 | 1833 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2004 | 1285 | 0.010 |
Why?
|
Up-Regulation | 1 | 2008 | 4205 | 0.010 |
Why?
|
Blood Glucose | 1 | 2013 | 6237 | 0.010 |
Why?
|
Cell Line | 2 | 2004 | 15987 | 0.010 |
Why?
|
Nasal Cavity | 1 | 2000 | 306 | 0.010 |
Why?
|
Insulin | 1 | 2013 | 6569 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 1986 | 1925 | 0.010 |
Why?
|
Stem Cells | 1 | 2011 | 3566 | 0.010 |
Why?
|
Immune Sera | 1 | 1997 | 639 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2008 | 2948 | 0.010 |
Why?
|
Inflammation | 1 | 2017 | 10534 | 0.010 |
Why?
|
Ovary | 1 | 2001 | 982 | 0.010 |
Why?
|
Histocytochemistry | 1 | 1997 | 723 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1997 | 1088 | 0.010 |
Why?
|
Quality Improvement | 1 | 2011 | 3730 | 0.010 |
Why?
|
Blotting, Western | 1 | 2004 | 5181 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1997 | 1583 | 0.010 |
Why?
|
Bromides | 1 | 1995 | 22 | 0.010 |
Why?
|
Deuterium Oxide | 1 | 1995 | 34 | 0.010 |
Why?
|
Sodium Compounds | 1 | 1995 | 30 | 0.010 |
Why?
|
Transfection | 1 | 2004 | 5884 | 0.010 |
Why?
|
Cell Division | 1 | 1983 | 4575 | 0.010 |
Why?
|
Antibody Specificity | 1 | 1997 | 1096 | 0.010 |
Why?
|
Thyroid Gland | 1 | 1982 | 1169 | 0.010 |
Why?
|
Body Water | 1 | 1995 | 342 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2000 | 3510 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2000 | 1516 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1997 | 1934 | 0.010 |
Why?
|
Cell Count | 1 | 1997 | 1833 | 0.010 |
Why?
|
Fats | 1 | 1993 | 102 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1995 | 1676 | 0.010 |
Why?
|
Carbohydrate Metabolism | 1 | 1993 | 265 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2008 | 10455 | 0.010 |
Why?
|
Guidelines as Topic | 1 | 1999 | 1407 | 0.010 |
Why?
|
Apoptosis | 1 | 2008 | 9714 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2000 | 6370 | 0.010 |
Why?
|
Enzyme Activation | 2 | 1987 | 3701 | 0.010 |
Why?
|
Risk | 1 | 2003 | 9684 | 0.010 |
Why?
|
Fura-2 | 1 | 1989 | 109 | 0.010 |
Why?
|
Child | 1 | 2017 | 77033 | 0.010 |
Why?
|
Calcium Gluconate | 1 | 1988 | 23 | 0.010 |
Why?
|
Lithium Carbonate | 1 | 1989 | 184 | 0.010 |
Why?
|
Benzofurans | 1 | 1989 | 141 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 1997 | 6397 | 0.010 |
Why?
|
Edetic Acid | 1 | 1988 | 277 | 0.010 |
Why?
|
Chronic Disease | 1 | 2003 | 9133 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 1997 | 6174 | 0.000 |
Why?
|
Electrolytes | 1 | 1988 | 282 | 0.000 |
Why?
|
Stimulation, Chemical | 1 | 1987 | 326 | 0.000 |
Why?
|
Decision Support Techniques | 1 | 1997 | 1957 | 0.000 |
Why?
|
Fluorides | 1 | 1987 | 126 | 0.000 |
Why?
|
Type C Phospholipases | 1 | 1987 | 292 | 0.000 |
Why?
|
Base Sequence | 1 | 1997 | 12804 | 0.000 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 1994 | 1539 | 0.000 |
Why?
|
Cell Membrane Permeability | 1 | 1987 | 589 | 0.000 |
Why?
|
Extracellular Space | 1 | 1987 | 594 | 0.000 |
Why?
|
Prognosis | 1 | 2005 | 28901 | 0.000 |
Why?
|
p-Aminohippuric Acid | 1 | 1984 | 36 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1997 | 18125 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1997 | 11347 | 0.000 |
Why?
|
Nucleotides | 1 | 1986 | 461 | 0.000 |
Why?
|
Infusions, Intravenous | 1 | 1988 | 2270 | 0.000 |
Why?
|
Renal Circulation | 1 | 1984 | 333 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1997 | 13002 | 0.000 |
Why?
|
Electric Stimulation | 1 | 1987 | 1769 | 0.000 |
Why?
|
Energy Metabolism | 1 | 1993 | 2896 | 0.000 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1987 | 2558 | 0.000 |
Why?
|
Combined Modality Therapy | 1 | 1993 | 8605 | 0.000 |
Why?
|
Norepinephrine | 1 | 1984 | 910 | 0.000 |
Why?
|
Transplantation, Autologous | 1 | 1986 | 2119 | 0.000 |
Why?
|
Postoperative Period | 1 | 1986 | 1835 | 0.000 |
Why?
|
Models, Biological | 1 | 1997 | 9609 | 0.000 |
Why?
|
Indomethacin | 1 | 1981 | 328 | 0.000 |
Why?
|
Prostaglandins | 1 | 1981 | 406 | 0.000 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 1981 | 364 | 0.000 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 1981 | 370 | 0.000 |
Why?
|
Plasma | 1 | 1980 | 573 | 0.000 |
Why?
|
Posture | 1 | 1980 | 966 | 0.000 |
Why?
|
Acute Disease | 1 | 1986 | 7128 | 0.000 |
Why?
|
Mice | 1 | 1997 | 81002 | 0.000 |
Why?
|
Aspirin | 1 | 1981 | 3268 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1986 | 25470 | 0.000 |
Why?
|